Protein flexibility is an important component of structure-based drug discovery

被引:110
作者
Carlson, HA [1 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.2174/1381612023394232
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Receptor-based drug discovery can increase the novelty of a hit list over ligand-based models that are dependent on known inhibitors. It is important to explore new conformational and chemical space, but it is difficult to predict the plasticity of the binding site. Receptor-based methods are usually based on crystal structures of ligand-protein complexes, and hit lists can be restricted to the size and shape of the receptor model. Many improvements that accommodate protein flexibility in computer-aided drug design are being developed. These methods are reviewed with the focus being techniques that move beyond the rotation of side chains. The use of multiple protein structures is emerging as the best choice for including more realistic changes in protein conformation, but the optimal way to using these structures is still unclear.
引用
收藏
页码:1571 / 1578
页数:8
相关论文
共 78 条
  • [51] Philippopoulos M, 1999, PROTEINS, V36, P87, DOI 10.1002/(SICI)1097-0134(19990701)36:1<87::AID-PROT8>3.0.CO
  • [52] 2-R
  • [53] Protein dynamics in enzymatic catalysis: Exploration of dihydrofolate reductase
    Radkiewicz, JL
    Brooks, CL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (02) : 225 - 231
  • [54] Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm
    Raymer, ML
    Sanschagrin, PC
    Punch, WF
    Venkataraman, S
    Goodman, ED
    Kuhn, LA
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 265 (04) : 445 - 464
  • [55] Sandak B, 1998, PROTEINS, V32, P159, DOI 10.1002/(SICI)1097-0134(19980801)32:2<159::AID-PROT3>3.3.CO
  • [56] 2-U
  • [57] Schaffer L, 1998, PROTEINS, V33, P295, DOI 10.1002/(SICI)1097-0134(19981101)33:2&lt
  • [58] 295::AID-PROT12&gt
  • [59] 3.0.CO
  • [60] 2-F